BioCentury | Feb 5, 2021
Management Tracks

Chugai names Okuda CEO; plus Astellas promotes Barretto-Ko to CBO, Goto to CSO and updates from Merck KGaA, Scholar Rock, Berkeley Lights, Catamaran and more

...named Deborah Wenkert SVP and CMO. The veteran of Amgen Inc. (NASDAQ:AMGN) was CMO of Precithera Inc....
BioCentury | Jul 28, 2017
Financial News

PreciThera raises C$36M series A

...Orphan bone disease newco PreciThera Inc. (Montreal, Canada) raised C$36 million ($28.6 million) on July 27 in...
...solidarité FTQ, CTI Life Sciences Fund and Emerillion Capital also participated. PreciThera Inc. , Montreal, Canada Julian Zhu PreciThera Inc....
BioCentury | Jul 27, 2017
Financial News

PreciThera raises C$36M in series A

...Orphan bone disease newco PreciThera Inc. (Montreal, Canada) raised C$36 million ($28.6 million) in an oversubscribed series...
...Beauparlant told BioCentury that current treatments are non-specific, targeting symptoms rather than root genetic causes. PreciThera's...
...PreciThera raised seed funding in the form of a consolidated loan from Sanderling and Emerillion. Julian Zhu PreciThera Inc....
Items per page:
1 - 3 of 3
BioCentury | Feb 5, 2021
Management Tracks

Chugai names Okuda CEO; plus Astellas promotes Barretto-Ko to CBO, Goto to CSO and updates from Merck KGaA, Scholar Rock, Berkeley Lights, Catamaran and more

...named Deborah Wenkert SVP and CMO. The veteran of Amgen Inc. (NASDAQ:AMGN) was CMO of Precithera Inc....
BioCentury | Jul 28, 2017
Financial News

PreciThera raises C$36M series A

...Orphan bone disease newco PreciThera Inc. (Montreal, Canada) raised C$36 million ($28.6 million) on July 27 in...
...solidarité FTQ, CTI Life Sciences Fund and Emerillion Capital also participated. PreciThera Inc. , Montreal, Canada Julian Zhu PreciThera Inc....
BioCentury | Jul 27, 2017
Financial News

PreciThera raises C$36M in series A

...Orphan bone disease newco PreciThera Inc. (Montreal, Canada) raised C$36 million ($28.6 million) in an oversubscribed series...
...Beauparlant told BioCentury that current treatments are non-specific, targeting symptoms rather than root genetic causes. PreciThera's...
...PreciThera raised seed funding in the form of a consolidated loan from Sanderling and Emerillion. Julian Zhu PreciThera Inc....
Items per page:
1 - 3 of 3